Is Finding Cancer Earlier Better? For Breast Cancer, the Answer May Be 'No'

Share this content:

(ChemotherapyAdvisor) – Mammography screening was found to lead to an overdiagnosis of breast cancer in 15% to 25% of cases, results of a decade-long study in Norway published in the April 3 issue of Annals of Internal Medicine has found.

The investigators defined overdiagnosis “as the percentage of cases of cancer that would not have become clinically apparent in a woman's lifetime without screening.” They compared invasive breast cancer incidence with and without screening using data from a nationwide mammography screening program in Norway gradually implemented from 1996 to 2005 in which women aged 50 to 69 years were invited to be screened.

A total of 39,888 patients with invasive breast cancer were included, 7,793 of whom were diagnosed after the screening program was initiated. Results showed that 15% to 25% of cases of cancer were overdiagnosed, translating to six to ten women overdiagnosed for every 2,500 women invited. Ductal carcinoma in situ was not studied.

The authors recommend “watch-and-wait” strategies with non-invasive, early-stage tumors. However, they recognize this approach may be difficult for women to support. “Ultimately, better tools are needed to reliably identify which breast cancer will be fatal without treatment and which can be safely observed over time without intervention, but we cannot wait for these tools to be developed,” the investigators wrote. They added that clinicians “have an ethical responsibility to alert women to this phenomenon,” given that most women are not aware overdiagnosis can exist.

The authors of an accompanying editorial point out under-recognized harms of overdiagnosis, including the anxiety of false-positive results; in addition, once diagnosed with cancer that otherwise would not have progressed, women are forever altered by that diagnosis.


Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs